Back to search

McMaster University

CATECHOLAMINE REGULATED PROTEIN 40 (CRP40): CLINICAL IMPLICATIONS IN PARKINSON’S DISEASE

Abstract

dc:description.abstract

<p>Parkinson’s disease (PD) is characterized by progressive cell death of the dopaminergic neurons of nigrostriatal pathway. Several causes have been implicated for PD via neurochemical research including mitochondrial dysfunction, oxidative stress, and protein misfolding, to list a few. The novel Catecholamine Regulated Protein 40 (CRP40) has certain dopaminergic and neuroprotective features that implicate its importance for PD research. Recent studies using post-mortem brain tissue of patients with PD found MOT-2/CRP40 depletion in the frontal cortex and substantia nigra. MOT-2/CRP40 reduction is also observed in striatal brain tissue samples from a hemi-lesioned preclinical animal model of PD. Most recently, work done at the University of Laval in collaboration McMaster University suggests that levels of CRP40 mRNA are in deficit in blood platelet samples from a primate model of PD.</p> <p>The studies presented in this thesis suggest that the CRP40 protein has a dual function with regards to PD. The full-length CRP40 binds dopamine and, upon injection at the striatum of 6-hydroxydopamine hemi-lesioned rats, alleviates behavioural symptoms for up to 7 days. On the other hand, a 7kDA fragment of CRP40 does not bind dopamine, but does confer the same alleviatory effect upon intra-striatal injection in 6-hydroxydopamine hemi-lesioned rats. Not only has a protein now been identified with novel potential as a therapeutic agent for PD, but also the approximate region of the CRP40 protein responsible for behavioural effects.</p> <p>The later studies of this thesis show that CRP40 is found dysregulated in platelets of PD patients and lymphocytes of SCZ patients. This evidence has revealed CRP40 as a novel PD biomarker, for which on going studies are now in place to explore the potential of CRP40 as a diagnostic for PD.</p>

Degree

thesis:*
Department dc:contributor.department
Neuroscience
Year dc:date.issued
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Groleau, Sarah E.
Advisors dc:contributor.advisor
  • Gabriele, Joe
  • Mishra, Ram

Subjects

dc:subject × 2

Identifiers

dc:identifier.*
Dc Identifier Other
opendissertations/8120
9218
4559786

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Groleau, Sarah E.. CATECHOLAMINE REGULATED PROTEIN 40 (CRP40): CLINICAL IMPLICATIONS IN PARKINSON’S DISEASE. 2013. http://hdl.handle.net/11375/13301